Viral caspase inhibitors CrmA and p35.
Zhou
Q
Q
Burnham Institute, La Jolla, California 92037, USA.
Salvesen
G S
GS
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D053148:Caspase 3; D061945:Caspase Inhibitors; D002460:Cell Line; D003001:Cloning, Molecular / Q000379:methods; D015608:Cowpox virus; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel / Q000379:methods; D004926:Escherichia coli; D007202:Indicators and Reagents; D007700:Kinetics; D008322:Mammals; D017924:Nucleopolyhedroviruses; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000378:metabolism; D015843:Serpins / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D018411:Spodoptera; D014764:Viral Proteins / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*
D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; D007202:Indicators and Reagents; D011994:Recombinant Proteins; D015843:Serpins; D014764:Viral Proteins; C081618:p35 protein, Nucleopolyhedrovirus; C074641:interleukin-1beta-converting enzyme inhibitor; D053148:Caspase 3